1.
Clin Infect Dis
; 74(7): 1271-1274, 2022 04 09.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34293119
RESUMO
Twenty-five B-cell-depleted patients (24 following anti-CD19/20 therapy) diagnosed with coronavirus disease 2019 had been symptomatic for a median of 26 days but remained antibody negative. All were treated with convalescent plasma with high neutralizing antibody titers. Twenty-one (84%) recovered, indicating the potential therapeutic effects of this therapy in this particular population.